SDDS-2022

Confirmed Renowned Speakers

Dr. H. Michael Shepard, President & CEO, Enosi Life Sciences, USA	Dr. Tom Blundell, Professor, University of Cambridge, UK	Dr. Ulo Langel, Professor, Stockholm University, Sweden
Dr. Mats Larsson, Professor, Department of Physics, Stockholm University, Sweden	Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK	Dr. Ferenc Hudecz, Professor, Department of Organic Chemistry, Eötvös L. University, Hungary
Dr. Sergey Suchkov, Professor, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia	Dr. Jian Yang, Senior Director, Digital Heath, Eli Lilly and Company, USA	Dr. Yehuda Shoenfeld, Professor, Sheba Medical Center, Tel-Aviv University, Israel
Dr. Arne Staby, Scientific VP, CMC Project Management, Biologics, Novo Nordisk A/S, Denmark	Dr. Michael Markert, Vice President and Global Head of CardioMetabolic Diseases Research, Boehringer Ingelheim, Germany	Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, AstraZeneca UK Limited, UK
Dr. Ved Srivastava, Vice President of Peptide Chemistry, Intarcia Therapeutics, USA	Dr. Sylvie Pucheu, Founder and CSO, CILcare, France	Dr. Andreas Seidl, Chief Operating Officer, Leukocare AG, Germany
Dr. Wilfried Dathe, External Consultant and Head of Medical Research, Heck Bio-Pharma GmbH, Germany	Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan	Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland
Dr. Klaus Groschner, Professor, Chair of Biophysics, Medical University of Graz, Austria	Dr. Yiqun Li, Head of IT Lilly Biotechnology Center, Eli Lilly and Company, USA	Dr. Joerg Grosse-Onnebrink, Head, University Children’s Hospital Münster, Germany
Dr. Steve Gardner, CEO, PrecisionLife Ltd, UK	Dr. Zhenghong Qin, Professor, Soochow University School of Pharmaceutical Science, China	Dr. Monika Tandon, Senior Vice President & Head, Glenmark Pharmaceuticals, India
Dr. Hartmut Beck, Science Fellow, Medicinal Chemistry, Bayer AG, Germany	Dr. Michael Hust, Professor for Biotechnology, Technische Universität Braunschweig, Germany	Dr. Asif M. Paker, Vice President, Clinical Development, SwanBio Therapeutics, USA
Dr. Dejun Tang, Senior Vice President, Firma Clinical Research, USA	Dr. Rob Sterling, Director of Business Development, Foster Delivery Science, USA	Dr. Ofer Toledano, Vice President of Research and Development, Sol-Gel Technologies Ltd, Israel
Dr. Michele Marzola, Co-Founder and CEO, Interceptin srl, Italy	Dr. Randolf Kerschbaumer, CEO, OncoOne Research & Development GmbH, Austria	Dr. Michael G. Tovey, Managing Director, EuroDiagnostica Biomonitor, France
Dr. Seung-Yong Seong, Professor, Seoul National University, South Korea	Dr. Xiaoyan Jiang, Professor, University of British Columbia, Canada	Dr. Stefan Stahl, Professor, KTH Royal Institute of Technology, Sweden
Dr. Ryszard Ostaszewski, Professor, Institute of Organic Chemistry, Polish Academy of Sciences, Poland	Dr. Igor V. Komarov, Scientific Advisor, Lumobiotics GmbH, Germany	Dr. Edmont Stoyanov, Technical Director, Nisso Chemical Europe GmbH, Germany
Dr. Eduard Korkotian, Professor, Weizmann Institute of Science, Israel	Dr. Lutz Fischer, Professor, University of Hohenheim, Germany	Dr. Olaf Gunther, Researcher, Regionales Schmerzzentrum Magdeburg, Germany
Dr. Methal Albarghouthi, Director, Analytical Sciences, Biopharmaceutical Development, AstraZeneca, USA	Dr. Michele Marzola, Co-Founder and Chief Executive Officer, Interceptin srl, Italy	Dr. Yoon-Won Kim, CEO, ImmuneMed; Professor, Hallym University, South Korea
Dr. Serge Bottari, Professor, GREPI, TIMC-IMAG, UMR 5525 CNRS - UGA, France	Dr. Anna Juncker-Jensen, Principal Scientist, NeoGenomics Laboratories, Inc., USA	Dr. John A. Cidlowski, Senior Investigator, National Institute of Environmental Health Sciences, USA
Dr. Urban Fagerholm, Founder & CEO, PROSILICO, Sweden	Dr. Dulcie A Mulholland, Professor, Department of Chemistry, University of Surrey, UK	Dr. Kiyoshi Eshima, President, Delta-Fly Pharma, Inc., Japan
Dr. Georg Richter, Director, Institute of Pathology in Hameln, Germany	Dr. Karine Roget, Chief Scientific Officer, Nexbiome Therapeutics, France	Dr. Peter M. Keller, Deputy Head of Diagnostics, University of Bern, Switzerland
Dr. John D. Chappell, Application & Service Director EMEA and Asia Pacific, Gyros Protein Technology, UK	Dr. Marlene E. Haffner, President and CEO, HaffnerAssociates, LLC , USA	Dr. Kamil Paruch, Professor, Department of Chemistry, Masaryk University, Czech Republic
Dr. Hai Rao, Professor, South University of Science and Technology, China	Dr. Sinthia Bosnic-Anticevich, Professor, University of Sydney, Australia	Dr. Milosevic Slavoljub, Vice President, Medigene AG, Germany
Mr. James Stumpff, Principal Consultant, PAREXEL, USA	Dr. Inga Poletaeva, Professor, Moscow State University, Russia	Dr. Salvatore Guccione, Professor, Central Drug Research Institute, Italy
Dr. Frank Staubli, Business Development Manager, Nebion AG, Switzerland	Dr. Susan W. Neadle, Sr. Director, Global Value Chain Quality Design, Johnson & Johnson, USA	Dr. Vakhtang Barbakadze, Professor, Tbilisi State Medical University, Georgia
Dr. Boris Mahltig, Professor, Niederrhein University of Applied Sciences, Germany	Dr. Shunying Liu, Professor, East China Normal University, China	Dr. José Luis Muñoz-Carrillo, Scientific Researcher, Cuauhtémoc Aguascalientes University, México
Dr. Chris Gwenins, Professor, Xi'an Jiaotong-Liverpool University, China	Dr. Shalini Andersson, Chief Scientist, AstraZeneca, Sweden	Dr. Yukio Yoneda, Professor Emeritus, The Institute of Prophylactic Pharmacology, Japan
Dr. Leandro G. Mieravilla, Global Manager, Cassara Biotech, Canada	Dr. Silvio Dutz, Professor, Technische Universität Ilmenau, Germany	Dr. Mazhar I. Khan, Professor, University of Connecticut, USA
Mr. Holger Krenz, Vice President Applications Development Europe, SiO2 Medical Products, Germany	Dr. Valery V. Tuchin, Professor, Saratov State University, Russia	Dr. Anis Rahman, President & CTO, Applied Research & Photonics, Inc., USA
Dr. Stefan R. Schmidt, Vice President ApplCOO/Head of Operations, BioAtrium AG, Switzerland	Dr. Stef Stienstra, Dutch Armed Forces/Royal Dutch Navy, the Netherlands	Dr. Kenneth Byron, Professor Emeritus, Loyola University Chicago Stritch School of Medicine, USA